LINCOLN PHARMACEUTICALS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/05/2019 ,inter alia, to consider and approve Consider and approve the Audited Standalone and Consolidated Financial Results of the Company for the Quarter and Year Ended on March 31, 2019, Recommendation of Dividend on Equity Shares of the Company for the Financial Year Ended on March 31, 2019, if any and Any other matter with the approval of the chair.

Pdf Link: Lincoln Pharmaceuticals Ltd. - Board Meeting Intimation for Consider And Approve The Audited Standalone And Consolidated Financial Results Of The Company For The Quarter And Year Ended On March 31, 2019 And Recommendation Of Dividend On Equity Shares If Any

Source : BSE - www.bseindia.com

comment COMMENT NOW